AWM Investment Company’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-98,173
Closed -$1.26M 100
2024
Q4
$1.26M Hold
98,173
0.15% 72
2024
Q3
$1.05M Buy
98,173
+25,000
+34% +$235K 0.13% 83
2024
Q2
$580K Sell
73,173
-423,779
-85% -$4.03M 0.08% 88
2024
Q1
$7.97M Hold
496,952
1.04% 34
2023
Q4
$6.82M Buy
+496,952
New +$5.7M 0.9% 37

Other funds holding RCEL

AWM Investment Company's RCEL Position: Q1 2025 in Review

AWM Investment Company sold out of Avita Medical (RCEL) in Q1 2025, closing a stake of 98,173 shares — an estimated $1.26M sold.

AWM Investment Company first reported a position in RCEL in Q4 2023 and held it in 5 quarters. The position peaked at $7.97M in Q1 2024. 74 funds tracked by Wall St. Rank hold RCEL as of Q1 2025.

  • AWM Investment Company reported no remaining Avita Medical position as of Q1 2025 after selling out during the quarter.
  • AWM Investment Company sold 98,173 Avita Medical shares in Q1 2025, an estimated $1.26M.
  • AWM Investment Company first reported a position in Avita Medical in Q4 2023 and held it in 5 quarters.
  • AWM Investment Company's Avita Medical position peaked at $7.97M in Q1 2024.
  • 74 funds tracked by Wall St. Rank held Avita Medical as of Q1 2025.

Based on AWM Investment Company's 13F filing for Q1 2025, filed 15 May 2025.